MedPath

Assessment of Diastolic Function in High Risk Patients Undergoing Major Vascular Surgery

Completed
Conditions
Diastolic Dysfunction
Aneurysm Aortic
Heart Failure
Registration Number
NCT03534440
Lead Sponsor
Medical University of Warsaw
Brief Summary

Patients scheduled for Thoracic Endovascular Aortic Repair (TEVAR) surgery will have transthoracic echocardiography evaluation of left ventricle diastolic function during the perioperative period.

Detailed Description

Patients undergoing TEVAR surgery are a high risk group of developing perioperative cardiovascular complications.

Left ventricle diastolic dysfunction is common in this group of patients because of the prevalence of risk factors: \> 60 years old, hypertension, smoking history and diabetes.

Because of many predisposing factors that occur during the surgery: stress respond, fluid shifts, anaesthesia and mechanical ventilation. Deterioration of the diastolic function is likely to occur in perioperative period

In this study, the investigators will evaluate change in left ventricle diastolic function as a marker for early detection of a myocardial failure in patients scheduled for an elective TEVAR surgery. The examination will be performed preoperatively, shortly after the surgery and 24 hours after the surgery.

Aim: The aim of the study is to evaluate the diastolic function of left ventricle in perioperative period after high risk surgery. This may provide a valuable information in preoperative risk stratification and postoperative therapy guidance.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • scheduled TEVAR
  • >60 years old
Exclusion Criteria
  • Atrial fibrillation or other non-sinus rhythms
  • Atrioventricular blocks
  • Heart rate change more than 25% postoperatively
  • Not adequate transthoracic view
  • Postoperative shock
  • Sepsis

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in left ventricle diastolic function in timeBaseline, 2 hours and 24 hours

Echocardiographic assessment of change in left ventricle diastolic function repeated in time intervals:

Baseline before the surgery, 2 and 24 hours after the surgery

Secondary Outcome Measures
NameTimeMethod
Change in biochemistry markers: troponinsBaseline, 2 hours and 24 hours

Assessment of change in level of troponins. Baseline before the surgery, 2 and 24 hours after the surgery

Length of stay in hospitalup to 14 days

Documentation of length of stay in hospital since the surgery

Change in left ventricle systolic functionBaseline, 2 hours and 24 hours

Echocardiographic assessment of change in left ventricle systolic function repeated in time intervals:

Baseline before the surgery, 2 and 24 hours after the surgery

Kidney function72 hours

Monitoring of glomerular filtration rate and requirement for a dialysis daily

Fluid balance72 hours

Monitoring of diuresis hourly, fluid losses and fluids intake

Change in biochemistry markers: brain natriuretic peptideBaseline, 2 hours and 24 hours

Assessment of change in level of brain natriuretic peptide. Baseline before the surgery, 2 and 24 hours after the surgery

Hemodynamic parameters: Heart rateBaseline, 2 hours and 24 hours

Heart rate during echocardiography evaluation.

Hemodynamic parameters: Systolic and diastolic pressureBaseline, 2 hours and 24 hours

Systolic and diastolic pressure measurements during echocardiography evaluation. Record vasopressors requirement.

Mortalityup to 30 days

Documentation of in-hospital mortality and 30 days mortality

Trial Locations

Locations (1)

Medical University Of Warsaw

🇵🇱

Warsaw, Mazovian, Poland

© Copyright 2025. All Rights Reserved by MedPath